§ Funding Round
Series B funding round for Checkmate Pharmaceuticals raising $27M in June 2017
Series B funding round for Checkmate Pharmaceuticals raising $27M in June 2017
| Investor | Firm Type | Partner |
|---|---|---|
Andreessen Horowitz | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Angel | carol gallagher | |
| Organization | — | |
Omega Funds | — | — |
| Organization | — | |
SV Health Investors | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Angel | james park | |
| Angel | Jason Wang | |
| Angel | jon brelig | |
| Angel | manik gupta | |
| Angel | Ralph Gootee | |
ben auspitzLEAD | Angel | ben auspitz |
| Organization | — |
This company has completed 5 funding rounds. Current round is highlighted.
Total Raised
$176M
Top Valuation
-
Checkmate Pharmaceuticals raised $27M in a Series B round.
The round was announced on 06/01/17.
The round was led by ben auspitz.
